Humatica Ltd. was retained to advise the Riverside Company on its investment in Alter Pharma, a Belgian pharmaceutical group. Alter Pharma distributes EU-sourced pharmaceutical products to wholesalers pharmacies and hospitals. It also develops and reformulates generic pharmaceuticals using GMP approved third-party manufacturers, and sells them internationally through partnerships
Humatica provided organisational due diligence services for this transaction.
To view press release: Humatica Advisor to Riverside for AlterPharma
Zurich, 10 July 2024 – Humatica realized unprecedented 89% fee revenue growth in the first half of 2024. Increased professional fees came from both recurring and…
Read moreLondon, 28 May 2024 – Humatica has officially been named as one of the UK’s Best Workplaces for Development™ 2024 by Great Place To Work®,…
Read moreHumatica is proud to announce being recognized as one of only 24 “gold” ranked change management consultants in the UK by consultancy.uk. The UK is…
Read more